Corporate Governance

Gerri Henwood


Gerri Henwood has served as a member of our board of directors since April 2015. Ms. Henwood currently serves as President and Chief Executive Officer and a director of Recro Pharmaceuticals, Inc., a publicly-traded, specialty pharmaceutical company developing non-opiod therapeutics for the treatment of acute pain. From 2006 to 2013, Ms. Henwood served as the President of Malvern Consulting Group. She is the co-founder of Auxilium Pharmaceuticals, Inc., and served as its President, Chief Executive Officer and director from 1999 to 2006. Prior to founding Auxilium, in 1985 Ms. Henwood founded and was President and Chief Executive Officer of a publically-traded contract research organization, IBAH, Inc., which was acquired by Omnicare, Inc. Prior to founding IBAH, Inc., Ms. Henwood began her career with Smith Kline & French, now part of GlaxoSmithKline plc, in the pharmaceutical management program, most recently as Group Director—Marketing in the International Pharmaceutical Division. Ms. Henwood currently serves on the board of directors of one private company. Ms. Henwood received a B.S. in Biology from Neumann College.

Independent Director
Contact Us

Tetraphase Pharmaceuticals, 480 Arsenal Way, Suite 110, Watertown, MA 02472

Tel 617-715-3600 | Fax 617-926-3557 | CONTACT AND MEDICAL INFORMATION

Forward Looking Statements | Terms of Use | Privacy Policy

Copyright © Tetraphase Pharmaceuticals       All rights reserved.


Please enter a valid email address.


Please enter a valid email address.


Share information about Tetraphase


Thank you! Your email has been sent.